Blocking IFNGR1 in the breast cancer cells prior to overnight incubation with CM of activated bulk T lymphocytes resulted in a concentration-dependent decrease in passage of the tumor cells through the in vitro BBB (Fig. 5a). This evidence concerns the gene IFNGR1 and breast cancer.